Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Checkmate Pharmaceuticals
Biotech
Seagen finally finds new CEO—Chutes & Ladders
Seagen finally finds new CEO; Biogen taps Sanofi vet to lead; Former Sage Therapeutics CEO to helm new biotech incubator.
Gabrielle Masson
,
Max Bayer
Nov 11, 2022 9:30am
Checkmate details troubled future if Regeneron deal fails
May 13, 2022 11:14am
Regeneron buys Checkmate Pharmaceuticals for $250M cash
Apr 19, 2022 9:01am
Checkmate plucks BMS exec to be new CEO
Feb 9, 2022 10:11am
Checkmate CEO exits one-asset biotech, board member fills post
Oct 28, 2021 10:30am
Novo helps lead Checkmate's $85M raise for single asset
Jun 11, 2020 7:30am
